E-submission
Search
- Page Path
- HOME > Search
Case Study
- TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
- Anurag Mehta, Himanshi Diwan, Divya Bansal, Manoj Gupta
- J Pathol Transl Med. 2022;56(1):53-56. Published online November 16, 2021
- DOI: https://doi.org/10.4132/jptm.2021.09.16
- 3,771 View
- 166 Download
- 2 Web of Science
- 3 Crossref
-
Abstract
PDF - SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized as a distinct subtype based on subtle differences in its clinical, morphological, and immunophenotypic attributes compared to other non–small cell lung carcinomas. We present here a case of SD-LUAD with curious thyroid transcription factor 1 (TTF1) expression in a morphologically heterogenous lung adenocarcinoma. The better differentiated area showed preservation of TTF1 expression, and a poorly differentiated tumor had loss of TTF1 expression with universal BRG1 loss.
-
Citations
Citations to this article as recorded by
- One Case of Non-Small Cell Lung Cancer with SMARCA4 Deletion Was Reported
允龙 宋
Medical Diagnosis.2024; 14(01): 137. CrossRef - Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma
Lei Zhang, Ting Sun, Xiao-Ye Wu, Fa-Ming Fei, Zhen-Zhen Gao
World Journal of Clinical Cases.2022; 10(29): 10501. CrossRef - Novel germline SMARCA4 mutation in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Anurag Mehta, Himanshi Diwan, Diksha Karki, Divya Bansal, Meenakshi Kamboj, Anila Sharma, Shrinidhi Nathany, Sakshi Mattoo, Dushyant Kumar
Current Problems in Cancer: Case Reports.2022; 8: 100205. CrossRef
- One Case of Non-Small Cell Lung Cancer with SMARCA4 Deletion Was Reported
First
Prev
